NAB-14
NAB-14 is a potent, selective, orally active and non-competitive GluN2C/2D antagonists with an IC50 of 580 nM for GluN1/GluN2D. NAB-14 shows >800-fold selective for recombinant GluN2C and GluN2D over GluN2A and GluN2B. NAB-14 can cross the blood-brain-barrier[1].
Product Specifications
CAS Number
1237541-73-9
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nab-14.html
Purity
98.26
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=C(C(NC2=CC=CC3=C2NC=C3)=O)C=C1)N(CC)CC
Molecular Formula
C20H21N3O3
Molecular Weight
351.40
References & Citations
[1]Swanger SA, et al. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons. ACS Chem Neurosci. 2018 Feb 21;9 (2) :306-319.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PDMH100299-01 20 µg
Recombinant Human DR6/TNFRSF21 Protein (His Tag)
Sign In for Pricing
View Details PDMH100299-02 100 µg
Recombinant Human DR6/TNFRSF21 Protein (His Tag)
Sign In for Pricing
View Details